article · Egyptian Journal of Veterinary Science
This study explored the potential of dietary supplementation of copper oxide nanoparticles (Cu-NP) and their effects on performance and health of gilthead seabream (Sparus aurata) fingerlings. Fish (N=270, 28.56 ± 1.205 g) were randomly distributed in 18 hapa in triplicate representing six treatments. Control group (Cu-NP0), (Cu-NP0.25), (Cu-NP0.5), (Cu-NP1.0), (Cu-NP1.5) and (Cu-NP2.0) in which fish received 0, 0.25, 0.5, 1.0, 1.5 and 2.0 mg/kg Cu-NP respectively for 90 days. Results revealed dietary supplementation of fish with Cu-NP can improve growth and feed utilization indices compared to Cu-NP0 (P < 0.05), with the best results displayed in Cu-NP1.0. A significant improvement of hematobiochemical parameters and lipase activity was exhibited in Cu-NP1.0 whereas the lowest values of these parameters were showed in Cu-NP2.0. Catalase, superoxide dismutase, and malonaldehyde showed a dose dependent improvement with the increase of Cu-NP dose and the highest values recorded in Cu-NP2.0 whereas the lowest malonaldehyde activity was observed in Cu-NP1.0. Fish exposure to 1 mg/Kg Cu-NP significantly increased phagocytic activity, phagocytic index, lysozyme activity and immunoglobulin M content. Compared to Cu-NP0, a significant dose-dependent elevation in the expression of apoptosis related gene (HSP70) and innate immune response gene (IL1β) whereas the maximum expression of growth regulating gene (ILGF-1) displayed in Cu-NP1.0. Intestinal and hepatopancreatic tissue histomorphology was improved in Cu-NPs-treated groups in ascending manner associated with increased doses then it was deteriorated with Cu-NP2.0 dose. Conclusively, dietary supplementation of gilthead seabream with 1 mg/kg diet Cu-NP improved growth performance, general health, antioxidant activity and immune response.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.21608/ejvs.2023.232453.1583
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.